Jakob Dupont, EVP, Head of R&D at Atara Biotherapeutics, Inc. (ATRA), sold 10,368 shares at $14.55 ($151K) on 2021-05-18, disclosed to the SEC on 2021-05-20.
Open-market sale of $151k ATRA by EVP, Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.55 | 5,184 | $75K | 50.0% |
| 2 | $14.55 | 5,184 | $75K | 50.0% |
| Total | $14.55 avg | 10,368 | $151K | 100% |
| Filing → |
| ATRA | SELL | 2022-11-18 | $19K | — | Filing → |
| ATRA | SELL | 2022-08-18 | $21K | — | Filing → |
| ATRA | SELL | 2022-05-19 | $21K | — | Filing → |